Repeated UTIs Signal Deadly Bladder Cancer Risk

A significant UK study published in The Lancet Primary Care has identified a strong link between repeated urinary tract infections (UTIs) and an elevated risk of bladder cancer, particularly in older adults. The research indicates that the frequency of UTIs within a short timeframe is crucial.

Adults aged 67 to 81 who suffered three UTIs within a six-month period faced a risk over five times higher than normal for developing bladder cancer. This risk escalated dramatically for those with five or more infections in the same timeframe, with their risk being over 13 times higher.

Experts suggest that persistent inflammation from recurrent infections triggers the body's repair mechanisms, increasing the chance of dangerous cell mutations. The study analyzed medical records of nearly 54,000 British patients, finding that timing was critical: three UTIs spread over a year posed a three-times higher risk, while the same number within six months raised the risk nearly fivefold.

This link was most pronounced in women, who are more susceptible to recurrent UTIs. The findings highlight a gap in current NHS guidance, as only about one in four eligible patients aged 60 or over with recurrent UTIs are referred to specialists to rule out cancer, leading to later diagnoses and poorer outcomes.

Conversely, hormone replacement therapy (HRT) showed a protective effect, potentially reducing bladder cancer risk by approximately 23%. This may be because some post-menopausal UTIs are linked to hormonal changes rather than underlying cancer. Prevention strategies include adequate water intake and avoiding bladder irritants like fizzy drinks, alcohol, and coffee.